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Summary
Introduction: Middle-ear angiosarcoma is a rare malignant tumor that requires early diagnosis
to allow satisfactory removal. The objective of the present study was to describe and discuss
the diagnosis and treatment of this rare malignant middle-ear tumor.
Case report: A 12-year-old girl was admitted for a left retroauricular mass and a budding left
external auditory canal tumor without associated peripheral facial nerve palsy. CT scan showed
a mastoid-region tumor extending to the external auditory canal with mastoid and occipi-
tal bone-loss. Tumor removal used a retroauricular approach. Postoperative diagnosis was of
angiosarcoma. At 12months’ regular follow-up, there were no signs of local recurrence.
Discussion and conclusion: Middle-ear angiosarcoma is a rare tumor, in which diagnosis is late
because early symptoms are not speciﬁc. A multidisciplinary approach is essential for efﬁcient
management.
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Introduction
Malignant tumor of the ear is infrequent, with an incidence
of 1 per six million of the population. Whatever the histologi-
cal type, a middle-ear location is exceptional [1]. Middle-ear
angiosarcoma is thus rare. Diagnosis should not be delayed,
so as to allow satisfactory tumor removal without risk of neu-
rologic sequelae. Prognosis is generally poor but depends on
the time to diagnosis [2]. The present observation provides
an opportunity to describe and discuss the diagnostic and
therapeutic management of middle-ear angiosarcoma.
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ase report
12-year-old girl was admitted for chronic unilateral left
torrhea with 2 years’ evolution, associated with retroau-
icular tumefaction. Clinically, she presented with a budding
umor ﬁlling the external auditory canal and a ﬁrm retroau-
icular mass of 6 cm diameter (Fig. 1). There was no
ssociated peripheral facial nerve palsy. CT scan conﬁrmed
he presence of a mastoid-region tumor extending to the
ympanum and external auditory canal. There was osteoly-
is of the mastoid and posterior external auditory canal wall
Fig. 2). Removal via a retroauricular approach used con-
hoplasty (Fig. 3). Immediate postoperative course showed
urgical site suppuration despite systematic empiric antibio-
herapy. There was also grade-3 facial nerve palsy (House
nd Brackmann classiﬁcation). The surgery site infection
.
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Figure 1 Retroauricular mass and external auditory canal.
Figure 2 Axial CT slice showing mastoid osteolysis.
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Figure 4 Histologic cross-section (HEX 100) showing several vasc
cells.igure 3 Mastoid-region tumor extending to external auditory
anal by osteolysis of the posterior canal wall.
as arrested by adapted antibiotherapy, and the facial
alsy recovered fully. Histologic examination of the surgical
pecimen found several vascular ﬁssures with endothelial
ell nucleus abnormalities, establishing the diagnosis of
iddle-ear angiosarcoma extending to the external audi-
ory canal (Fig. 4). Complementary radiochemotherapy was
rescribed but could not be performed, radiotherapy not
eing available in Côte d’Ivoire. The patient was referred
o the oncology department, where chemotherapy was
dministered. At 12months’ follow-up, there was no sign
f recurrence.
iscussion
rimary malignant tumors of the middle-ear are rare, repre-
enting 5% of ear cancers [1]. Eighty percent of middle-ear
umors are in fact extensions of outer-ear neoplasia, notably
f the external auditory canal [2]. In the present case, the
rimary site was the mastoid, with secondary extension to
he tympanum and external auditory canal by lysis of the
osterior canal wall. Mean age at onset depends on the
ular ﬁssures with cytonuclear abnormality of the endothelial
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Table 1 Middle-ear angiosarcoma cases in the literature.
Authors Country Number
Cernyl [7] Czechoslovakia 1
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RFishbun [8] Russia 1
Alvares et al. [1] Brazil 1
Present case Côte d’Ivoire 1
histologic type [2,3]: for sarcoma, onset is during the ﬁrst
decade of life [4]. Chronic otitis is a sarcoma risk factor
[1,2,3,5]. The present patient presented with chronic otor-
rhea, which in our opinion was rather a consequence of the
tumor. It is, however, nonspeciﬁc to malignant ear tumor,
inducing error in diagnosis, which accounts for the long
delay (24months) in treatment in the present case. Moffat
et al. [5] reported a shorter mean interval to consultation
of 6 months. Thus, in case of chronic otorrhea resistant
to treatment for infection, and especially when otoscopy
ﬁnds a polyp or external auditory canal collapse, CT assess-
ment should be undertaken without delay [5]. In the present
case, osteolysis seen on CT imaging suggested middle-
ear cholesteatoma. A diagnosis of middle-ear angiosarcoma
presupposes considerable experience on the part of both
the clinician and the radiologist. Only anatomopathologi-
cal examination of a biopsy sample taken from the suspect
lesion enables diagnosis to be conﬁrmed. In the present
case, diagnosis was conﬁrmed only by histologic examina-
tion of the surgical specimen. Table 1 presents the cases
of middle-ear angiosarcoma retrieved from the literature
[7,8]. Although there is no consensus, the 1990 Pittsburgh
TNM classiﬁcation of external auditory canal squamous cell
carcinoma [9,10] is the most widely used. It is based on pre-
operative clinical examination and CT ﬁndings [9], and has
the advantage of being of both therapeutic and prognostic
interest. A minor revision of the classiﬁcation was made in
2000 [9].
Treatment of middle-ear tumor depends on the degree
of extension [3]. Classically, it associates surgery and/or
radiochemotherapy. Surgery should follow the rules of can-
cer surgery rather than the general principles of ear surgery
[5]. It should be large-scale and adapted, generally con-
sisting in petrosectomy and requiring a dedicated technical
platform [6,10]. In the present case, large-scale petromas-
toid dissection allowed satisfactory tumor removal. The
prescribed radiochemotherapy could not be carried out,
radiotherapy not being available in Côte d’Ivoire. Only adju-
vant chemotherapy could be administered, following the
usual protocol. Prognosis depends on the interval to diag-
nosis and on tumor extension. In evolved forms, surgical
[89
emoval is incomplete in 50% of cases, accounting for the
igh rate of local recurrence at 10months [3]. In the present
ase, there was no local recurrence at 12months’ follow-up.
onclusion
iddle-ear angiosarcoma is a rare tumor, like other middle-
ar tumors. Diagnosis is delayed by the non-speciﬁcity of
arly signs, leading the otologist to suspect an infectious
tiology. CT is of great diagnostic interest, on condition that
he radiologist be sufﬁciently experienced. Histologic exam-
nation of a biopsy sample, to be taken from any suspect
esion, is the key to diagnosis and the only guarantee of
ffective treatment. We would stress the need for multidis-
iplinary management associating otologist, radiologist and
ncologist.
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